• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Raysearch Laboratories

232.40 SEK

-0.34 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.34 %
+7.29 %
+19.67 %
+5.88 %
+1.93 %
-30.52 %
+267.14 %
+164.69 %
+316.67 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Read more
Market cap
7.97B SEK
Turnover
8.9M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13.8.
2026

Interim report Q2'26

3.11.
2026

Interim report Q3'26

10.2.
2027

Annual report '26

Press release03.07.2026 klo 10.23

Yonsei Cancer Center expands use of RayStation

Raysearch Laboratories
Press release01.07.2026 klo 15.34

RaySearch releases RayStation v2026

Raysearch Laboratories
Press release29.06.2026 klo 13.56

RayIntelligence v2026: Advancing oncology analytics

Raysearch Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release26.06.2026 klo 11.45

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release18.06.2026 klo 11.15

RaySearch enters the Vietnamese market

Raysearch Laboratories
Regulatory press release16.06.2026 klo 15.14

Utilization of authorization to acquire own shares

Raysearch Laboratories
Press release05.06.2026 klo 10.35

RaySearch to showcase new advances in particle therapy at PTCOG 64

Raysearch Laboratories
Press release21.05.2026 klo 14.38

Antony Lomax joins RaySearch to strengthen leadership in particle therapy

Raysearch Laboratories
Press release18.05.2026 klo 10.06

First patients treated with RayCare at Raigmore Hospital

Raysearch Laboratories
Press release13.05.2026 klo 18.30

RaySearch to showcase groundbreaking innovations at ESTRO 2026

Raysearch Laboratories
Press release12.05.2026 klo 11.05

First online adaptive treatment on TrueBeam using RayStation and RayCare

Raysearch Laboratories
Regulatory press release07.05.2026 klo 21.10

Bulletin from the Annual General Meeting 2026

Raysearch Laboratories
Regulatory press release29.04.2026 klo 08.30

Interim report first quarter 2026: Strong long-term performance and raised margin target

Raysearch Laboratories
Press release27.04.2026 klo 11.20

Institut Hartmann selects RayStation and RayCare

Raysearch Laboratories
Press release22.04.2026 klo 12.10

Invitation to presentation of RaySearch’s interim report for the first quarter of 2026

Raysearch Laboratories
Regulatory press release19.04.2026 klo 20.45

Günther Mårder resigns from the Board of RaySearch

Raysearch Laboratories
Press release17.04.2026 klo 09.45

RaySearch receives first RayCare order in China

Raysearch Laboratories
Regulatory press release15.04.2026 klo 17.15

RaySearch publishes Annual Report for 2025

Raysearch Laboratories
Regulatory press release02.04.2026 klo 11.00

Notice of Annual General Meeting 2026

Raysearch Laboratories
Press release19.03.2026 klo 11.05

First patient treated in Ukraine using RayStation

Raysearch Laboratories